0001213900-21-019653.txt : 20210401
0001213900-21-019653.hdr.sgml : 20210401
20210401162048
ACCESSION NUMBER: 0001213900-21-019653
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210330
FILED AS OF DATE: 20210401
DATE AS OF CHANGE: 20210401
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Amusa Gbolahan
CENTRAL INDEX KEY: 0001761120
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38762
FILM NUMBER: 21798351
MAIL ADDRESS:
STREET 1: 17 STATE STREET 21 FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10004
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BiomX Inc.
CENTRAL INDEX KEY: 0001739174
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 17 STATE STREET, 16TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10004
BUSINESS PHONE: 646-465-9000
MAIL ADDRESS:
STREET 1: 17 STATE STREET, 16TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10004
FORMER COMPANY:
FORMER CONFORMED NAME: Chardan Healthcare Acquisition Corp.
DATE OF NAME CHANGE: 20180430
4
1
ownership.xml
X0306
4
2021-03-30
0
0001739174
BiomX Inc.
PHGE
0001761120
Amusa Gbolahan
C/O BIOMX LTD., 7 PINHAS SAPIR
ST., FLOOR 2
NESS ZIONA,
L3
7414002
ISRAEL
1
0
0
0
Common Stock Options - Right to Buy
7.02
2021-03-30
4
A
0
15200
0
A
2031-03-30
Common Stock
15200
15200
D
The options vest and become exercisable over four years, with 25% of the shares subject to the option vesting on March 30, 2022, and the remainder vesting in 12 equal quarterly installments over three years.
/s/ Gbola Amusa
2021-04-01